University of Virginia Health System Apr 21 2026 Millions of Americans are still battling potentially deadly hepatitis C even though they could be cured with antiviral drugs they are not receiving, a new analysis reveals. University of Virginia School of Medicine researcher Sanjay Kishore, MD, and colleagues at Mass General Brigham looked at prescribing trends for the drugs, known as direct-acting antivirals. They found that prescriptions rose rapidly when the drugs were first introduced in